A higher dose of 80 mg/kg administered in two 40 mg/kg doses showed a slight trend towards prolonged survival (9±1.4 days), however, all animals still rejected before day-10.
← all excerpts
The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.
1
—
—